Orungal (Itraconazole)

Itraconazole, the active ingredient in Orungal, is an azole antifungal presented as a oral formulation for systemic and superficial mycoses treatment in adults and children. It inhibits fungal growth and is used for a range of serious fungal infections.

GNH USA supplies Orungal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Orungal is an azole antifungal that acts on a broad spectrum of fungal pathogens causing systemic and superficial infections. - Blastomycosis: reduces fungal burden and promotes clinical recovery. - Histoplasmosis: helps eradicate the organism and prevents disease progression. - Aspergillosis: limits invasive growth of fungi and improves respiratory function. - Candidiasis: clears the infection from mucosal surfaces and bloodstream. - Superficial mycoses: treats skin, nail and hair infections caused by dermatophytes.

Side effects of  Orphan  ​   ​   ...

I...

...